Jiang Cao

2.3k total citations
75 papers, 1.9k citations indexed

About

Jiang Cao is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jiang Cao has authored 75 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 30 papers in Oncology and 17 papers in Genetics. Recurrent topics in Jiang Cao's work include Estrogen and related hormone effects (8 papers), Multiple Myeloma Research and Treatments (8 papers) and Cancer-related gene regulation (8 papers). Jiang Cao is often cited by papers focused on Estrogen and related hormone effects (8 papers), Multiple Myeloma Research and Treatments (8 papers) and Cancer-related gene regulation (8 papers). Jiang Cao collaborates with scholars based in China, United States and Canada. Jiang Cao's co-authors include Kuifeng He, Robert Vescio, Haohao Wang, Lisong Teng, Lisong Teng, Zhonghai Guan, Qiaoli Zheng, Ketao Jin, Gary J. Schiller and César O. Freytes and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Jiang Cao

73 papers receiving 1.9k citations

Peers

Jiang Cao
Dorina Gui United States
Amit Verma United States
Ai-Min Hui United States
Robert A. Blake United States
David Verbel United States
Dorina Gui United States
Jiang Cao
Citations per year, relative to Jiang Cao Jiang Cao (= 1×) peers Dorina Gui

Countries citing papers authored by Jiang Cao

Since Specialization
Citations

This map shows the geographic impact of Jiang Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang Cao more than expected).

Fields of papers citing papers by Jiang Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang Cao. The network helps show where Jiang Cao may publish in the future.

Co-authorship network of co-authors of Jiang Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang Cao. A scholar is included among the top collaborators of Jiang Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang Cao. Jiang Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Sen, Jun Liu, Yang Liu, et al.. (2022). Combination of RSK inhibitor LJH-685 and FLT3 inhibitor FF-10101 promoted apoptosis and proliferation inhibition of AML cell lines. Cellular Oncology. 45(5). 1005–1018. 6 indexed citations
2.
Jiang, Fan, Mingjie Xia, Yanan Zhang, et al.. (2022). Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury. Frontiers in Immunology. 13. 993168–993168. 37 indexed citations
3.
Su, Xingyun, Xiaoxia Jiang, Tuo Zhang, et al.. (2020). VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid Cancer. Translational Oncology. 13(2). 441–451. 12 indexed citations
4.
Wu, Lingyan, Muhammad Saif Ur Rahman, Xiaodong Teng, et al.. (2019). Promoter Hypomethylation Is Responsible for Upregulated Expression of HAI-1 in Hepatocellular Carcinoma. Disease Markers. 2019. 1–12. 9 indexed citations
5.
Rahman, Muhammad Saif Ur, et al.. (2017). Sensitization of gastric cancer cells to alkylating agents by glaucocalyxin B via cell cycle arrest and enhanced cell death. Drug Design Development and Therapy. Volume 11. 2431–2441. 11 indexed citations
6.
Zheng, Qiaoli, Jiang Cao, Nada Hamad, et al.. (2016). Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia. Journal of Translational Medicine. 14(1). 82–82. 8 indexed citations
7.
Xu, Xin, Xingyun Su, Kuifeng He, et al.. (2015). Establishment and characterization of GCSR1, a multi-drug resistant signet ring cell gastric cancer cell line. International Journal of Oncology. 46(6). 2479–2487. 8 indexed citations
8.
Zheng, Qiaoli, Haijian Wu, & Jiang Cao. (2015). Circulating Adiponectin and Risk of Endometrial Cancer. PLoS ONE. 10(6). e0129824–e0129824. 15 indexed citations
9.
Yu, Xiongfei, Haohao Wang, Haiyong Wang, et al.. (2015). Advances in the targeted therapy of liposarcoma. OncoTargets and Therapy. 8. 125–125. 22 indexed citations
10.
Teng, Lisong, Xingyun Su, Xin Xu, et al.. (2014). ER-α36: a novel biomarker and potential therapeutic target in breast cancer. OncoTargets and Therapy. 7. 1525–1525. 32 indexed citations
11.
Chen, Huiqiang, Xianbao Liu, Han Chen, et al.. (2013). Role of SIRT1 and AMPK in mesenchymal stem cells differentiation. Ageing Research Reviews. 13. 55–64. 90 indexed citations
12.
Yang, Beibei, et al.. (2012). Antitumor potential of SLPI promoter controlled recombinant caspase-3 expression in laryngeal carcinoma. Cancer Gene Therapy. 19(5). 328–335. 13 indexed citations
13.
Jin, Ketao, Kuifeng He, Fei Teng, et al.. (2011). FP3: a novel VEGF blocker with antiangiogenic effects in vitro and antitumour effects in vivo. Clinical & Translational Oncology. 13(12). 878–884. 10 indexed citations
14.
Han, Na, Ketao Jin, Kuifeng He, Jiang Cao, & Lisong Teng. (2011). Protease-activated receptors in cancer: A systematic review. Oncology Letters. 2(4). 599–608. 43 indexed citations
15.
Wei, Qun, Wen Zhou, Boning Gao, et al.. (2010). Tumor-Suppressive Functions of Leucine Zipper Transcription Factor–Like 1. Cancer Research. 70(7). 2942–2950. 32 indexed citations
16.
Teng, Lisong, et al.. (2010). Advances in Combination of Antiangiogenic Agents Targeting VEGF-binding and Conventional Chemotherapy and Radiation for Cancer Treatment. Journal of the Chinese Medical Association. 73(6). 281–288. 22 indexed citations
17.
Zheng, Yi, Zhenzhen Xu, Xiao‐Chen Zhang, et al.. (2010). Quantitative profiles of the mRNAs of ER-α and its novel variant ER-α36 in breast cancers and matched normal tissues. Journal of Zhejiang University SCIENCE B. 11(2). 144–150. 17 indexed citations
18.
Yang, Beibei, Hua Jiang, Jia Chen, et al.. (2009). Dendritic cells pulsed with GST–EGFR fusion protein: Effect in antitumor immunity against head and neck squamous cell carcinoma. Head & Neck. 32(5). 626–635. 7 indexed citations
19.
Xie, Xiaojie, Jianan Wang, Jiang Cao, & Xing Zhang. (2006). Differentiation of bone marrow mesenchymal stem cells induced by myocardial medium under hypoxic conditions. Acta Pharmacologica Sinica. 27(9). 1153–1158. 66 indexed citations
20.
Berenson, James R., Robert Vescio, Jiang Cao, et al.. (1995). Multiple Myeloma Clones are Derived from a Cell Late in B Lymphoid Development. Current topics in microbiology and immunology. 194. 25–33. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026